• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13G/A filed by Acadia Healthcare Company Inc.

    5/11/26 1:22:52 PM ET
    $ACHC
    Medical Specialities
    Health Care
    Get the next $ACHC alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    (Amendment No. 1)


    ACADIA HEALTHCARE COMPANY, INC.

    (Name of Issuer)


    Common stock, $.01 par value

    (Title of Class of Securities)




    00404A109

    (CUSIP Number)
    03/31/2026

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)




    schemaVersion:


    SCHEDULE 13G

    CUSIP Number(s):
    00404A109


    1Names of Reporting Persons

    THE GOLDMAN SACHS GROUP, INC.
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    1,453,488.72
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    1,454,430.72
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    1,464,125.72
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    1.6 %
    12Type of Reporting Person (See Instructions)

    HC, CO


    SCHEDULE 13G

    CUSIP Number(s):
    00404A109


    1Names of Reporting Persons

    GOLDMAN SACHS & CO. LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    NEW YORK
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    1,453,488.72
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    1,454,430.72
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    1,464,125.72
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    1.6 %
    12Type of Reporting Person (See Instructions)

    BD, OO, IA


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    ACADIA HEALTHCARE COMPANY, INC.
    (b)Address of issuer's principal executive offices:

    4020 ASPEN GROVE DR STE 900, FRANKLIN, X1, 37067
    Item 2. 
    (a)Name of person filing:

    THE GOLDMAN SACHS GROUP, INC.| GOLDMAN SACHS & CO. LLC
    (b)Address or principal business office or, if none, residence:

    The Goldman Sachs Group, Inc. 200 West Street New York, NY 10282| Goldman Sachs & Co. LLC 200 West Street New York, NY 10282
    (c)Citizenship:

    THE GOLDMAN SACHS GROUP, INC. - Delaware| GOLDMAN SACHS & CO. LLC - New York
    (d)Title of class of securities:

    Common stock, $.01 par value
    (e)CUSIP No.:

    00404A109
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    See the response(s) to Item 9 on the attached cover page(s).
    (b)Percent of class:

    See the response(s)to Item 11 on the attached cover page(s).
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    See the response(s) to Item 5 on the attached cover page(s).

     (ii) Shared power to vote or to direct the vote:

    See the response(s) to Item 6 on the attached cover page(s).

     (iii) Sole power to dispose or to direct the disposition of:

    See the response(s) to Item 7 on the attached cover page(s).

     (iv) Shared power to dispose or to direct the disposition of:

    See the response(s) to Item 8 on the attached cover page(s).

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Checkbox checked    Ownership of 5 percent or less of a class
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    Not Applicable
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.


    See Exhibit (99.2)
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    THE GOLDMAN SACHS GROUP, INC.
     
    Signature:Name: Sam Prashanth
    Name/Title:Attorney-in-fact
    Date:04/24/2026
     
    GOLDMAN SACHS & CO. LLC
     
    Signature:Name: Sam Prashanth
    Name/Title:Attorney-in-fact
    Date:04/24/2026
    Exhibit Information

    EXHIBIT (99.1) JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the Common stock, $.01 par value, par value $ per share, of ACADIA HEALTHCARE COMPANY, INC. and further agree to the filing of this agreement as an Exhibit thereto. In addition, each party to this Agreement expressly authorizes each other party to this Agreement to file on its behalf any and all amendments to such Statement on Schedule 13G. Date: THE GOLDMAN SACHS GROUP, INC. By:/s/ Sam Prashanth ---------------------------------------- Name: Sam Prashanth Title: Attorney-in-fact GOLDMAN SACHS & CO. LLC By:/s/ Sam Prashanth ---------------------------------------- Name: Sam Prashanth Title: Attorney-in-fact EXHIBIT (99.2) ITEM 7 INFORMATION The securities being reported on by The Goldman Sachs Group, Inc. ("GS Group"), as a parent holding company, are owned, or may be deemed to be beneficially owned, by Goldman Sachs & Co. LLC ("Goldman Sachs"), a broker or dealer registered under Section 15 of the Act and an investment adviser registered under Section 203 of the Investment Advisers Act of 1940. Goldman Sachs is a subsidiary of GS Group. EXHIBIT (99.3) ITEM 4 INFORMATION *In accordance with the Securities and Exchange Commission Release No. 34-39538 (January 12, 1998) (the "Release"), this filing reflects the securities beneficially owned by certain operating units (collectively, the "Goldman Sachs Reporting Units") of The Goldman Sachs Group, Inc. and its subsidiaries and affiliates (collectively, "GSG"). This filing does not reflect securities, if any, beneficially owned by any operating units of GSG whose ownership of securities is disaggregated from that of the Goldman Sachs Reporting Units in accordance with the Release. The Goldman Sachs Reporting Units disclaim beneficial ownership of the securities beneficially owned by (i) any client accounts with respect to which the Goldman Sachs Reporting Units or their employees have voting or investment discretion or both, or with respect to which there are limits on their voting or investment authority or both and (ii) certain investment entities of which the Goldman Sachs Reporting Units act as the general partner, managing general partner or other manager, to the extent interests in such entities are held by persons other than the Goldman Sachs Reporting Units.

    Get the next $ACHC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACHC

    DatePrice TargetRatingAnalyst
    6/3/2026$30.00Hold → Buy
    Jefferies
    5/4/2026$39.00Outperform → Strong Buy
    Raymond James
    1/22/2026$15.00Buy → Hold
    Jefferies
    12/3/2025$14.00Outperform → Market Perform
    Leerink Partners
    12/3/2025$13.00Neutral → Underperform
    BofA Securities
    9/10/2025$25.00Buy → Neutral
    BofA Securities
    8/14/2025$26.00Strong Buy → Outperform
    Raymond James
    2/28/2025$43.00 → $35.00Overweight → Equal Weight
    Barclays
    More analyst ratings

    $ACHC
    SEC Filings

    View All

    SEC Form 8-K filed by Acadia Healthcare Company Inc.

    8-K - Acadia Healthcare Company, Inc. (0001520697) (Filer)

    5/18/26 5:15:03 PM ET
    $ACHC
    Medical Specialities
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Acadia Healthcare Company Inc.

    SCHEDULE 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)

    5/15/26 7:24:39 AM ET
    $ACHC
    Medical Specialities
    Health Care

    SEC Form S-8 filed by Acadia Healthcare Company Inc.

    S-8 - Acadia Healthcare Company, Inc. (0001520697) (Filer)

    5/11/26 5:15:54 PM ET
    $ACHC
    Medical Specialities
    Health Care

    $ACHC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Duckworth David M. claimed ownership of 750 shares (SEC Form 3)

    3 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)

    5/11/26 5:06:31 PM ET
    $ACHC
    Medical Specialities
    Health Care

    Director Fucci Michael was granted 6,331 shares, increasing direct ownership by 29% to 28,152 units (SEC Form 4)

    4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)

    5/8/26 5:23:44 PM ET
    $ACHC
    Medical Specialities
    Health Care

    Director Waud Reeve B was granted 15,907 shares, increasing direct ownership by 27% to 75,859 units (SEC Form 4)

    4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)

    5/8/26 5:01:07 PM ET
    $ACHC
    Medical Specialities
    Health Care

    $ACHC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Acadia Healthcare Announces First Quarter 2026 Results

    Company Increases Full Year 2026 Adjusted EBITDA and Adjusted EPS Guidance Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced financial results for the first quarter ended March 31, 2026. First Quarter 2026 Results Revenue totaled $828.8 million, a 7.6% increase compared with the first quarter of 2025 Same-facility revenue increased 7.3% compared with the first quarter of 2025, including an increase in revenue per patient day of 5.6% and an increase in patient days of 1.6% Net income attributable to Acadia totaled $0.05 per diluted share, compared with $0.09 per diluted share in the prior-year period Adjusted net income attributable to

    4/29/26 4:05:00 PM ET
    $ACHC
    Medical Specialities
    Health Care

    National Veterinary Associates Appoints Todd S. Young as Chief Financial Officer

    National Veterinary Associates (NVA) announced the appointment of Todd S. Young as Chief Financial Officer, effective May 1, 2026. Young will serve on the company's executive leadership team and report to Chief Executive Officer John Bruno. "I am thrilled to welcome Todd to NVA," said Bruno. "He has spent his career leading world-class finance teams in human and animal healthcare, and his public company experience and deep industry knowledge are exactly what we need as we enter our next phase of growth." Young brings more than 25 years across human and animal healthcare, including more than a decade as a public company CFO. Most recently, he served as CFO of Acadia Healthcare (NASDAQ:AC

    4/24/26 9:00:00 AM ET
    $ACHC
    $ELAN
    Medical Specialities
    Health Care
    Biotechnology: Pharmaceutical Preparations

    Acadia Healthcare Appoints David Duckworth as Interim Chief Financial Officer

    Reaffirms Financial Guidance for First Quarter and Full Year 2026 Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced the appointment of David Duckworth, former Chief Financial Officer of Acadia, as Interim Chief Financial Officer, effective May 1, 2026. Duckworth succeeds Todd Young, who is departing from the Company to pursue a CFO role at a private equity-backed animal health company. Young will remain with the Company through April 30, 2026, and will participate in the Company's first quarter earnings call scheduled for the morning of April 30. Debra K. Osteen, Chief Executive Officer of Acadia, said, "We are pleased to welcome David back as Int

    4/23/26 4:15:00 PM ET
    $ACHC
    Medical Specialities
    Health Care

    $ACHC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Acadia Healthcare upgraded by Jefferies with a new price target

    Jefferies upgraded Acadia Healthcare from Hold to Buy and set a new price target of $30.00

    6/3/26 8:05:16 AM ET
    $ACHC
    Medical Specialities
    Health Care

    Acadia Healthcare upgraded by Raymond James with a new price target

    Raymond James upgraded Acadia Healthcare from Outperform to Strong Buy and set a new price target of $39.00

    5/4/26 8:30:20 AM ET
    $ACHC
    Medical Specialities
    Health Care

    Acadia Healthcare downgraded by Jefferies with a new price target

    Jefferies downgraded Acadia Healthcare from Buy to Hold and set a new price target of $15.00

    1/22/26 8:24:52 AM ET
    $ACHC
    Medical Specialities
    Health Care

    $ACHC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Acadia Healthcare Company Inc.

    SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)

    11/14/24 1:28:32 PM ET
    $ACHC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Acadia Healthcare Company Inc.

    SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)

    11/12/24 9:50:14 AM ET
    $ACHC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Acadia Healthcare Company Inc.

    SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)

    11/8/24 10:52:39 AM ET
    $ACHC
    Medical Specialities
    Health Care

    $ACHC
    Leadership Updates

    Live Leadership Updates

    View All

    National Veterinary Associates Appoints Todd S. Young as Chief Financial Officer

    National Veterinary Associates (NVA) announced the appointment of Todd S. Young as Chief Financial Officer, effective May 1, 2026. Young will serve on the company's executive leadership team and report to Chief Executive Officer John Bruno. "I am thrilled to welcome Todd to NVA," said Bruno. "He has spent his career leading world-class finance teams in human and animal healthcare, and his public company experience and deep industry knowledge are exactly what we need as we enter our next phase of growth." Young brings more than 25 years across human and animal healthcare, including more than a decade as a public company CFO. Most recently, he served as CFO of Acadia Healthcare (NASDAQ:AC

    4/24/26 9:00:00 AM ET
    $ACHC
    $ELAN
    Medical Specialities
    Health Care
    Biotechnology: Pharmaceutical Preparations

    Acadia Healthcare Appoints David Duckworth as Interim Chief Financial Officer

    Reaffirms Financial Guidance for First Quarter and Full Year 2026 Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced the appointment of David Duckworth, former Chief Financial Officer of Acadia, as Interim Chief Financial Officer, effective May 1, 2026. Duckworth succeeds Todd Young, who is departing from the Company to pursue a CFO role at a private equity-backed animal health company. Young will remain with the Company through April 30, 2026, and will participate in the Company's first quarter earnings call scheduled for the morning of April 30. Debra K. Osteen, Chief Executive Officer of Acadia, said, "We are pleased to welcome David back as Int

    4/23/26 4:15:00 PM ET
    $ACHC
    Medical Specialities
    Health Care

    Acadia Healthcare Appoints Daniel Cancelmi to Board of Directors

    Wade D. Miquelon to Retire from the Board at Upcoming Annual Meeting Acadia Healthcare Company, Inc. (NASDAQ:ACHC) ("Acadia") today announced that it has appointed Daniel Cancelmi to its Board of Directors, effective immediately. Mr. Cancelmi is a seasoned finance leader with an expansive knowledge of healthcare and a proven track record of driving superior financial performance. Most recently, he served as Executive Vice President and Chief Financial Officer of Tenet Healthcare Corporation, where he played a significant role in the company's transformation and in strengthening its balance sheet. Over the course of his three-decade career at Tenet, he held a range of finance roles of in

    3/12/26 4:15:00 PM ET
    $ACHC
    Medical Specialities
    Health Care

    $ACHC
    Financials

    Live finance-specific insights

    View All

    Acadia Healthcare Announces First Quarter 2026 Results

    Company Increases Full Year 2026 Adjusted EBITDA and Adjusted EPS Guidance Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced financial results for the first quarter ended March 31, 2026. First Quarter 2026 Results Revenue totaled $828.8 million, a 7.6% increase compared with the first quarter of 2025 Same-facility revenue increased 7.3% compared with the first quarter of 2025, including an increase in revenue per patient day of 5.6% and an increase in patient days of 1.6% Net income attributable to Acadia totaled $0.05 per diluted share, compared with $0.09 per diluted share in the prior-year period Adjusted net income attributable to

    4/29/26 4:05:00 PM ET
    $ACHC
    Medical Specialities
    Health Care

    Acadia Healthcare Announces Date for First Quarter 2026 Earnings Release

    Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that it will release its first quarter 2026 results on Wednesday, April 29, 2026, after the close of the market. Acadia will also conduct a conference call with institutional investors and analysts on Thursday, April 30, 2026 at 9:00 a.m. ET. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the "Investors" section of the website. The webcast of the conference call will be available for 30 days. About Acadia Healthcare Acadia is a leading provider of behavioral healthcare services across the United States. As of December 31, 2025, Acadia operated a network of 277 behavioral healthcare fa

    4/8/26 10:00:00 AM ET
    $ACHC
    Medical Specialities
    Health Care

    Acadia Healthcare Announces Fourth Quarter and 2025 Results

    Company Provides First Quarter and Full Year 2026 Guidance Debbie Osteen Joins Acadia as Chief Executive Officer Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced financial results for the fourth quarter and year ended December 31, 2025. Fourth Quarter 2025 Results Revenue totaled $821.5 million, a 6.1% increase compared with the fourth quarter of 2024, supporting full-year revenue results above the Company's previously issued guidance range Same facility revenue increased 4.4% compared with the fourth quarter of 2024, including an increase in patient days of 3.1% and an increase in revenue per patient day of 1.3% Net loss attributable

    2/25/26 7:00:00 AM ET
    $ACHC
    Medical Specialities
    Health Care